Where does Greiner Bio-one North America, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Greiner Bio-one North America, Inc. ranks #35,565 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Greiner Bio-one North America, Inc. hold?

Greiner Bio-one North America, Inc. holds 7 US utility patents granted between 2019 and 2024, spanning 13 technology areas.

What is Greiner Bio-one North America, Inc.'s Innovation Score?

Greiner Bio-one North America, Inc. has an Innovation Score of 33.2 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Greiner Bio-one North America, Inc.'s patent grant rate increasing or decreasing?

Greiner Bio-one North America, Inc.'s recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Greiner Bio-one North America, Inc.'s patents?

Greiner Bio-one North America, Inc.'s patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Greiner Bio-one North America, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Greiner Bio-one North America, Inc.

Q: What technology areas does Greiner Bio-one North America, Inc. focus on?

Greiner Bio-one North America, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents, ranking #1,801 of 4,144 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Greiner ranks #35,565 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#35,565
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.2/100): 13.7
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35565 · US Corporation #35,565 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,565/49,997
PHOTO-FINISH Greater Than AB
CPC-FOCUS C12N · 13 areas
INNOV-THIN 33.2/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Greater Than AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Greiner’s 33.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (22%) Velocity 5.0 pts (15%) Breadth 12.7 pts (38%) Claim depth 8.2 pts (25%)

Qualcomm Incorporated · highest

85
Greiner Bio-one… · this assignee

33
3D Lighting… · lowest

7

What this shows Greiner's Innovation Score is 33.2/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Greiner?

Each dot is one of Greiner’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Greiner’s own 13.7 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Greiner vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Greiner's grants concentrate

Greiner Bio-one North America, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 71.4% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2021. By volume, Greiner sits between Greater Than AB and Grintech GmbH.

Greiner's three-year grant acceleration

Greiner Bio-one North America, Inc. shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Greater Than AB

7
Green Biologics

7
Green Li-ion PTE

7
Green Wave Power…

7
Grena USA

7
Grenergy Opto

7
Gridview Optical…

7
Grintech

7
Greiner Bio-one N… ◀

7

What this shows Greiner holds 7 patents at rank #35,482, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Greiner

By rank, the assignees closest to #35,482 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Greiner's primary technology class.

Greiner's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Greiner Bio-one North America, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	42.9%
2021	1	14.3%
2024	3	42.9%

Which technologies does Greiner Bio-one North America, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Greiner Bio-one North America, Inc.'s patent record in context - here's where to go next.

Greiner Bio-one North America, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 71.4% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #35,565 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Greiner Bio-one North America, Inc. against Greater Than AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.